Sarah Schram

Stock Analyst at William Blair

(n/a)
# 4,654
Out of 4,981 analysts
1
Total ratings
n/a
Success rate
-29.39%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sarah Schram

Denali Therapeutics
Jan 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $14.19
Upside: -